Please find below a list of all of the oral and poster abstracts presented at UK Kidney Week 2018

To search for a particular topic or keyword, press Ctrl+F and enter your search term.

Click on the poster title to download the abstract.

Oral Presentation Abstracts

Communicating with Patients

O01- Assessing the demand for short animated information videos to enhance knowledge and understanding of renal conditions for patients, carers and healthcare professionals.

Arvind Nagra; Consultant Paediatric Nephrologist,

Southampton Children's Hospital

 

O02 - The impact of an integrated Renal Supportive Care Service on symptom burden, advanced care planning and place of death for patients with advanced chronic kidney disease managed without dialysis.

Claire Douglas; Consultant in Palliative Medicine

NHS Tayside

 

Raine Award presentation

O03 - The Host Immune Response to Cytomegalovirus is Associated with Reduced Efficacy of a T-cell Dependent Pneumococcal Vaccine in ANCA-Associated Vasculitis

Dimitrios Chanouzas; Clinical Lecturer / Specialist Registrar

University Hospital Birmingham / University of Birmingham

 

O04 - Key psychosocial issues causing distress in HD patients: problems, need and demand for psychosocial service provision

Maaike Seekles; Research Associate

University of Salford

O05 - Genomic Rearrangement Events in the RCA Cluster as a Cause of Atypical Haemolytic Uraemic Syndrome

Patrick Walsh; Academic Paediatric Trainee

Newcastle University

 

O06 - Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitis

Dimitrios Chanouzas; Clinical Lecturer / Specialist Registrar

University Hospital Birmingham / University of Birmingham

 

Three Minute Heroes

Sponsored by Kidney Research UK

O07 - Immunosuppression reduction following renal transplantation is the rule rather than the exception in recipients aged 60 and over

Trijntje Rennie; Transplant Fellow

Royal Infirmary of Edinburgh

 

O08 - Renal Medicine Recruitment Challenge – The UK experience

Alvin Karangizi; St3 Renal Medicine

Worcestershire Royal Hospital

O09 - A pilot project using Point of Care Creatinine Testing for early identification and management of Sepsis-Associated Acute Kidney Injury in nursing home residents. Evaluation of technology and design of the project.

Josh Storrar; St4

Salford Royal Hospital

O10 - Symptom Burden According To Dialysis Day of the Week in Three Times a Week Hemodialysis Patients

Pann Ei Hnynn Si; Renal Registrar

Sheffield Teaching Hospital NHS Foundation Trust

O11 - B lymphocytes mediate acute kidney injury

Akimichi Inaba; Mrc Clinical Research Fellow

University of Cambridge

O12 - Making every contact count; flu vaccination provision in the haemodialysis unit allows high levels of protection in a flu outbreak

Clara Day; Consultant Nephrologist

Queen Elizabeth Hospital Birmingham

O13 - Perspectives of Pregnancy Experience in Women with Chronic Kidney Disease: A questionnaire study using the Rare Renal Diseases Registry (RaDaR)

Olivia Snowball; Research Midwife

King's College Hospital

 

O14 - The Clinicopathological Spectrum of IgG4-Related Disease in North West London

Stephanie Poo; Doctor

Imperial College London

 

O15 - A novel podocyte phenotype of TRPC6 KO mice and the importance of the protein interaction between TRPC6 and calpain in health and disease

Louise Farmer; Research Associate

University of Bristol

 

O16 - Changes in psychosocial workforce provision 2017- National UK Audit

Paula Ormandy

University of Salford

 

O17 - Aurora Kinase Inhibitors Prevent Experimental Chronic Kidney Disease

Ian Logan; NIHR Clinical Lecturer

Newcastle Hospitals

 

O18 - Investigating the role of microRNAs in Acute Kidney Injury

Lucy Newbury; Pdra

Cardiff University

 

O19 - The Hyaluronan Synthase-1 (HAS1) isoenzyme promotes differentiation to a distinct subset of myofibroblasts that limit fibrosis progression.

Aled Williams; Clinical Research Fellow

Cardiff University

 

O20 - Urinary exosomes as a source of biomarkers of disease progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Katie Raby; Phd Student

University College London

 

O21 - SOX9 is a critical regulator of extracellular matrix deposition during kidney fibrosis

Sayyid Raza; Clinical Research Fellow

University of Manchester

 

O22 - Characterising the role of tissue-resident innate immune cells in urinary tract infection

Alex Riding

University of Cambridge

 

AKI

O23 - The prevalence of infectious aetiology in patients with community acquired AKI with a particular focus on patients from care homes.

James Tollitt; Research Fellow

Salford Royal NHS Trust

O24 - Quantitative Longitudinal Relaxation Time (T1) As Part of Multiparametric MRI Mapping Reveals Distinct Patterns of Renal Injury in AKI and CKD

Huda Mahmoud

University of Nottingham

 

O24.1 - The effects of plasma exchange and reduced-dose glucocorticoids during remission-induction for treatment of severe ANCA-associated vasculitis

Michael Walsh

Mcmaster University

 

Transition - CPD session

O25 - The impact of dialysis treatment on the psychological health of young adults: data from the SPEAK study

Alexander Hamilton; Tony Wing Clinical Research Fellow

University of Bristol

 

O26 - Psychosocial health and lifestyle behaviours in young adults receiving RRT compared to the general population: data from the SPEAK study

Alexander Hamilton; Tony Wing Clinical Research Fellow

University of Bristol

 

Cardiorenal

 O27 - Is the Left Ventricular Hypertrophy in Chronic Kidney Disease Adaptive or Maladaptive?

Shanmugakumar Chinnappa

Consultant Nephrologist

Doncaster and Bassetlaw Teaching Hospitals

 

O28 - The use of four or more drugs for intensive control of blood pressure is associated with detrimental renal effects in SPRINT

Indy Dasgupta; Consultant Nephrologist

Heartlands Hospital Birmingham

O29 - Effect of Allopurinol on Left Ventricular Mass in Haemodialysis Patients - a Randomised Controlled Trial

Elaine Rutherford; Clinical Lecturer/Renal Specialist Registrar

University of Glasgow

 

Anaemia

O30 - Evaluating the impact of routine colecalciferol on erythropoietin (EPO) requirements

Sharon Huish; Renal Dietitian

University Hospital Coventry

O31 - The Efficacy of Ascorbate-Rich Dialysate to Attenuate Anaemia in Maintenance Hemodialysis Patients

Ioannis Griveas; Consultant Nephrologist

Helenic Open University

 

O32 - Randomised controlled trial comparing high-dose versus low-dose intravenous iron supplementation in haemodialysis: the PIVOTAL trial (Proactive IV irOn Therapy in dialysis patients): rationale, study design, and baseline data

Claire White; Clinical Trial Manager

King’s College Hospital

 

Genetics and renal disease - Basic Science session

O33 - A novel ANCA-associated vasculitis genetic risk score (AAV GRS) identifies AAV in UK Biobank and may determine phenotypes

Robert Kimmitt; Academic F2

Royal Devon and Exeter NHS Foundation Trust

O34 - Total RNA Sequencing and Ingenuity Pathway Analysis Reveal Shared Gene Expression Profiles for Protection Conferred by Direct and Indirect Ischaemic Preconditioning

David Foxwell; Clinical Research Fellow

Cardiff University

O35 - DGKE Nephropathy

Vicky Brocklebank; Renal Registrar/clinical Research Training Fellow

Newcastle University

O36 - Analysis of Genome-Wide Arterial Media-Specific DNA-Methylation Demonstrates No Epigenetic Evidence of Aging but Reveals New Targets in CKD-Associated Cardiovascular Pathology.

Ben Caplin; Senior Clinical Lecturer

UCL

 

Leadership

O37 - Do Countries with an Opt-Out Organ Donation System Have Better Organ Donor Rates And/Or Transplantation Activity? An Empirical Analysis of OECD Countries

Muzna Babiker; CT2 trainee in medicine 

Queen Elizabeth Hospital

 

Kidney Health Delivering Excellence: Strategies for Development

O38 - The Variation in Hospitalisation and Mortality Following Non-Attendance for Haemodialysis According to Dialysis Day of the Week in a European Cohort: Further Evidence if Harm from the Two-Day Break in Three Times a Week Haemodialysis

James Fotheringham; Consultant Nephrologist

Sheffield Kidney Institute

 

O39 - Innovative ways of working across a healthcare system to improve outcomes of patients with kidney disease

Emma Vaux; Consultant Nephrologist

Royal Berkshire NHS Foundation Trust

 

O40 - The Relationship Between Patient Activation Level and Self-Performed Treatment Related Tasks Among Patients Receiving In-Centre Haemodialysis: The Share HD Cohort Study.

James Fotheringham; Consultant Nephrologist

Sheffield Kidney Institute

 

O41- Patient Perspectives of Target Weight Management and Ultrafiltration during Haemodialysis

Megan Glyde; Phd Student

University of Leeds

 

Exercise and Lifestyle

O42 - A Behaviour Change Intervention Designed to Reduce the Risk of Abnormal Glucose Metabolism After Renal Transplantation: Methodology from the Caviar Study

Joanne Driscoll; Dietician

Queen Elizabeth Hospital

O43 - Mortality and Morbidity following Renal Rehabilitation in patients with CKD: The effect of programme completion and change in exercise capacity

Sharlene Greenwood; Consultant Renal Physiotherapist

King's College Hospital

 

O44 - A 12-week Renal Rehabilitation programme can produce long-term physical function and exercise capacity gains in patients with CKD

Ellen Castle; Senior Renal Rehab Physiotherapist

King's College Hospital

 

Renal Nutrition

O45 - Vitamin D metabolite levels are associated with muscle mass and function but not intramuscular regulatory pathways in non-dialysis CKD

Thomas Wilkinson; Research Associate

University of Leicester

O46 - Energetic Cost of Protein Turnover in Chronic Kidney Disease

Sivakumar Sridharan; Consultant Nephrologist

Lister Hospital

O47 - Are we using Intradialytic Parenteral Nutrition effectively and appropriately in haemodialysis?

Nicola Marsh; Dietitian

 

Paediatric Nephrology

O48 - Validating the use of bioimpedance spectroscopy for assessment of fluid status in children

Indy Dasgupta; Consultant Nephrologist

Heartlands Hospital Birmingham

 

O49 - Haemodiafiltration (HDF) improves the cardiovascular risk profile compared to conventional haemodialysis (HD) in children – the HDF, Heart and Height (3H) trial

Rukshana Shroff; Consultant in Paediatric Nephrology

Great Ormond Street Hospital NHS Foundation Trust


O50 - Focal adhesion components are altered in childhood nephrotic syndrome

Abby Huckle; Medical Student

University of Manchester

 

Which outcomes matter to patients?

O51 - Haemodynamic stability is associated with better patient reported outcomes in individuals undergoing frequent dialysis at home using NxStage System 1.

Nicholas Sangala; Consultant

Queen Alexandra Hospital

O52 - Associations Between Patient Activation, Patient Characteristics and Patient Outcomes

Rachel Gair; Patient Measures - Programme Lead

UK Renal Registry

 

O53 - The Experience of Chronic Kidney Disease Patients: The Results of the 2017 UK Renal Registry / Kidney Care UK Chronic Kidney Disease Patient Reported Experience Measure

Janine Hawkins; Research Fellow

University of Hertfordshire

 

Young Investigator Award

O54 - The Role of the Podocyte in Shiga Toxin Associated Haemolytic Uraemic Syndrome

Emily Bowen; Clinical Research Fellow

University of Bristol

 

O55 - Aldosterone related glomerular injury can be prevented through matrix metaloprotease 2 and 9 inhibition and glycocalyx preservation

Matthew Butler; MRC Clinical Reseach Training Fellow

University of Bristol

O56 - Distinguishing the Metabolic and Osmotic Effects of Raised Glucose in Human Proximal Tubule Cells

Xinlu Pan; Phd Student, St George's

University of London

 

O57 - P2X7 expression on human neutrophils and PBMC in ANCA associated vasculitis

Maria Prendecki; Clinical Research Training Fellow

Imperial College

 

CKD

O58 - Coding CKD in primary care matters: evaluation of a CKD learning health system in east London.

Sally Hull; Reader In Primary Care Development

Queen Mary University of London

 

O59 - An IgAN genetic risk score analysis to estimate prevalence of IgA Nephropathy in 344 000 in UK Biobank

Kittiya Sukcharoen; Academic Clinical Fellow, Speciality Training Registrar In Renal Medicine,

Royal Devon and Exeter Foundation Trust

 

O60 - Assessment of Chronic Kidney Disease using Multi-Parametric MRI: Reproducibility, Correlation with Histology and Progression

Huda Mahmoud

University of Nottingham

 

Multi-Morbidity in Renal Replacement Therapy

O61 - What are the most commonly reported symptoms of depression amongst Haemodialysis patients? A descriptive comparison of patients from two ethnic backgrounds

Shivani Sharma; Associate Dean and Head of Psychology

University of Hertfordshire

O62 - How common are neurocognitive disorders in patients with diabetes and Chronic Kidney disease: Results from a community cohort of patients in North Wales.

Peter Hobson; Clinical Research Scientist,

Betsi Cadwardr University Health Board

 

O63 - Managing distress in people with ESRD: people’s ability to cope with ESRD is impaired by a combination of smaller problems and larger worries.

Kim Sein; Research Fellow

University of Birmingham

 

O64 - Impact of integrating modified geriatric assessment into routine dialysis care: extended patient outcomes

Carol Bartholomew, Specialist Renal Elderly Care nurse

Imperial College Healthcare NHS Trust

 

O65 - Fatal Haemodialysis Access Haemorrhage – A Twenty Year Case Series from One Network

Rupert Major; Academic Clinical Fellow

University of Leicester

O66 - Frailty in the Outpatient Haemodialysis Unit: Identification to Enable Multidisciplinary Management

Ailish Nimmo; Renal Registrar

NHS Lothian

 

Prescribe or not to prescribe: Issues to consider

O67 - Non-adherence to immunosuppressants following renal transplantation: Outcomes from a systematic review

Abigail Hucker; PhD Student

University of Hertfordshire

 

O68 - Non-adherence to Antihypertensive Medications is Related to Total Pill Burden

Dr Awais Hameed; Clinical Research Fellow

Heartlands Hospital

 

Diabetes in Renal Disease

O69 - ENHIDE Telehealth Primary Care Support of Adults with Diabetes and Chronic Kidney Disease

Peter Winocour; Clinical Director Consultant Diabetologist,

Enhide

 

Late Breaking Abstract Presentations

O70 - Determining Feasibility of Randomisation to high vs. ad libitum water Intake in Polycystic Kidney Disease: The DRINK Randomised Feasibility Trial

Ragada El-damanawi,

University of Cambridge

 

O71 - Noninvasive Monitoring of Vascular Access Health

Dave Kuraguntla

Graftworx

 

O72 - DUPDN- Development of Diagnostic Urinary Panel for Diabetic Nephropathy: A model to predict progressive CKD in diabetic patients

Mysore Phanish,

SW Thames Institute for Renal Research, Renal Unit, St Helier Hospital

 

O73 - Cystatin C Reduction Ratio as a Marker of Hemodialysis Adequacy: Strong Association with Survival

Enric Vilar

East and North Herts NHS Trust

 

O74 - Acute Kidney Injury Calculated using Admission Serum Creatinine Underestimates the Impact of 30-Day and 1-Year Mortality after Acute Stroke

Julia Arnold

University Hospitals Birmingham NHS Foundation Trust

 

O75 - Elevated blood (1-3)-B-D glucan causes apparent endotoxemia in dialysis patients and is associated with inflammation

Jonathan Wong

East and North Herts NHS Trust

 

WEDNESDAY MODERATED POSTERS

 

Group 1: Clinical - Diabetes and the kidney (treatment and outcomes) and Clinical -  Cardiovascular Disease

Moderators: Richard Haynes and Sharmila Bandyopadhay

 

P001      Management of adults with diabetes on the haemodialysis unit; experience of a District General Hospital               

Bahareh Arsalanizadeh

North West Anglia, NHS Foundation Trust, Peterborough City Hospital

 

P002      An audit of Joint British Diabetes Society guidelines for the management of adults with diabetes on the haemodialysis unit.        

Laura Baines

NUTH

 

P003      Use of Renin-Angiotensin-Aldosterone-System inhibitors in heart failure patients with CKD; role of hyperkalaemia

Debasish Banerjee         

St Georges University Hospital NHS Foundation Trust

 

P004      Role of a multidisciplinary clinic in manging patients referred to novel “CKD-Heart Failure” clinic

Debasish Banerjee         

St Georges University Hospital NHS Foundation Trust

 

P005      Role of Cardio-Renal MDT in managing high-risk patients on the kidney transplant waitlist             

Debasish Banerjee         

St Georges University Hospital NHS Foundation Trust

 

P006      Association of Non-alcoholic fatty liver disease with renal progression in advanced diabetic nephropathy

Rajkumar Chinnadurai   

Salford Royal NHS Foundation Trust

 

P007      Nano-technology based Multi Analyte Point of Care (PoC) Diagnostic Device: Validation and Clinical Application in Early Diabetic Kidney Disease        

Indy Dasgupta  

Heartlands Hospital Birmingham

 

P008      Patients with Diabetes receiving Haemodialysis – are they being over-medicated?            

Amanda Davis   

Royal Cornwall Hospitals Trust & Cornwall Partnership Foundation Trust

 

P009      CMV seropositivity is independently associated with ischaemic heart disease in chronic kidney disease

Alvin Karangizi  

Worcestershire Royal Hospital

 

P010      DETERMINANTS OF CHANGE IN ARTERIAL STIFFNESS OVER 5 YEARS IN EARLY CKD              

Natasha Mcintyre           

Graduate Entry School of Medicine, University of Nottingham

 

P011      CARDIAC BIOMARKERS LACK PREDICTIVE UTILITY IN END STAGE RENAL DISEASE 

Sanjeev Pramanik            

University Of Manchester

 

P012      Amplification of cortisol signalling in chronic kidney disease is associated with inflammation, cardiovascular pathology and impaired glycaemic control.          

Michael Sagmeister       

University Of Birmingham

 

Group 2: Clinical - Acute Kidney Injury

Moderated by Andrew Lewington and Kristin Veighey

P013      Functional hypoaldosteronism post adrenalectomy: an under recognised phenomenon.

Kathryn Griffiths             

King's College Hospital Trust

 

P014      Acute kidney injury electronic alerts: mixed methods evaluation of their implementation into secondary care, utilising Normalization Process Theory  

Nigel Kanagasundaram 

Newcastle upon Tyne Hospitals NHS Foundation Trust

 

P015      Mitochondrial haplogroup and the risk of acute kidney injury following cardiac bypass surgery

Nigel Kanagasundaram 

Newcastle upon Tyne Hospitals NHS Foundation Trust

 

P016      Post-operative Acute Kidney  Injury (AKI) in patients operated for emergency surgery for fracture neck of femur.

Bhavna Pandya

Aintree University Hospital NHS Foundation Trust

 

P017      Prevention of Hospital Acquired Acute Kidney Injury (AKI)  through the use of an In Hospital AKI Team

Gayathri Rajakaruna      

Lister Hospital, Stevanage

 

P018      Medication prescriptions after admission with hospital coded acute kidney injury in Wales            

Tim Scale            

Morriston Hospital

 

P019      Optimising the management of Acute Kidney Injury (AKI) at a District General Hospital – a Quality Improvement Project

Miguel Sequeira Campos             

King's College London

 

P020      The Renoprotective value of Leukodepletion in Heart Valve surgery: an external feasibility randomized controlled trial.

Laurie Solomon

Lancashire Teaching Hospitals Foundation Trust

 

P021      Interventions at multiple stages in patient pathways help in reducing the incidence and complications arising from Acute Kidney Injury (AKI)  

Shalabh Srivastava          

City Hospitals Sunderland

 

P022      Hyperkalaemia in the Emergency Department   

Natalie Whitton

Great Western Hospital

 

P023      Should we use Salbutamol in acute hyperkalaemia?

Natalie Whitton

Great Western Hospital

 

P024      A Holistic approach in managing Acute Kidney Injury led to significant reduction in Mortality.

The Introduction of Digital AKI Power Plans.

Khaled  Abdulnabi          

Wirral University Hospital

 

Group 3: Clinical -  Acute Kidney Injury

Moderated by Joe Wang and Mark Thomas

 

P025      Improving the care of patients with Acute Kidney Injury stage 3 using a multifaceted approach.   

Becky Bonfield 

University Hospital Southampton NHS Foundation Trust

 

P026      Improving Timeliness of Medication Review in Patients with Acute Kidney Injury (AKI)

Louise Delany   

St Helens and Knowsley NHS Trust

 

P027      MINERALS IN THE URINE OF WOMEN WITH OR WITHOUT PRE-ECLAMPSIA           

David Gardner  

University Of Nottingham

 

P028      Predicting risk of recurrent AKI: a systematic review        

Hilda Hounkpatin            

University Of Southampton

 

P029      Barriers and enablers to the implementation of a complex intervention for acute kidney injury: a qualitative evaluation of the Tackling AKI study from the perspective of the implementing teams.

Laura Lamming 

University Of Bradford

 

P030      CrossFit-Induced Rhabdomyolysis: A Case Report             

Monica Parker  

The Newcastle-upon-tyne NHS Foundation Trust

 

P031      The NHS England biochemical detection algorithm for AKI: assessment of potential alert burden and of expected alert transitions in an emergency admissions population           

Samuel Urwin

The Newcastle Upon Tyne Hospitals NHS Foundation Trust

 

P032      Incidence and Mortality of Acute Kidney Injury in a Large Primary Care Population

Gang Xu              

University Hospitals of Leicester

 

P033      Effects of Properdin in Mouse Renal Ischemia-Reperfusion Related Injury and Recovery

Bin Yang              

University Of Leicester

 

P034      Confirmed involvement of TRPM7 in apoptosis and inflammatory response in renal ischemia reperfusion injuries

Bin Yang              

University Of Leicester

 

Group 4: Clinical - Mineral Bone Disorder and Clinical – Anaemia

Moderated by Fouad Al Baaj and Morwena Wood

 

P035      A retrospective audit examining bone parameters in haemodialysis patients in relation to prescribed phosphate binders and active vitamin D analogues          

Caroline Bird     

University Hospital Coventry & Warwickshire NHS Trust

 

P036      PHOSPHATE MANAGEMENT FROM THE PATIENT'S PERSPECTIVE: A QUALITATIVE STUDY EXPLORING THE EXPERIENCES OF ADULTS UNDERGOING HAEMODIALYSIS

Helen Botham

Salford Royal NHS Foundation Trust

 

P037      QIP: Intravenous Iron Service at SaTH. Increasing CKD specialist nursing time to start a MDT Low Clearance Clinic

Sourabh Chand

Shrewsbury and Telford NHS Trust

 

P038      UK Calciphylaxis Study:  Clinical Characteristics and Outcomes-An update             

Rajkumar Chinnadurai   

Salford Royal NHS Foundation Trust

 

P039      Phosphate control in Satellite Dialysis Centre Patients - an audit of Dietetics and Medical management   

Jonathan Gamble            

Queen Alexandra Hospital

 

P041      The Role of DEXA Scans in Diagnosing Post-Transplant Renal Bone Disease

Kyle Hallas          

Lancashire Teaching Hospitals Trust

 

P042      Risk and Impact of Bone Fracture on an End Stage Renal Failure Cohort

Holly Mabillard 

NHS

 

P043 Maintaining safe practice in blood transfusion care: A study analysing the effectiveness of e-learning to underpin qualified nurses knowledge required for maintenance of competence in blood transfusion practice

Zari Mousapour
Middlesex University/ Royal Free London NHS trust

 

P044      Single centre study to find out the safety and efficacy of etelcalcetide in haemodialysis patients who are intolerant to cinacalcet 

Arvind Singh      

Gloucestershire Royal Hospital

 

P045      Effects of SNF472 on Wound Healing in Calciphylaxis (Calcific Uremic Arteriolopathy) Patients: Results from a Phase 2 Open-Label Single-Arm Trial       

Smeeta Sinha    

Salford Royal NHS Foundation Trust

 

Group 5: Clinical - Behaviour change and Psychosocial Aspects

Moderated by Emma Coyne and Helen Collinson

 

P046      Tunnelled dialysis catheters – are they always necessary?

Jyoti Baharani   

Heart Of England Foundation Trust

 

P047      An audit investigating the knowledge of long-term dialysis patients on the adverse effects of hyperphosphataemia and their adherence with phosphate binding medication

Frederick Downes           

Russells Hall Hospital

 

P048      Fast and fearless, or slow and scared? Fear of falling, balance, and gait speed in chronic kidney disease   

Thomas Wilkinson           

University Of Leicester

 

Group 6: Clinical -  Patient education/involvement and experience and Clinical -  MDT Education / research

Moderated by Nicola Thomas and Rachel Gair

 

P049      Multiple Myeloma; an uncommon presentation of a common neurological complication.

Mansoor Ali       

Calderdale and Huddersfield Hospitals NHS Trust

 

P050      Evaluation of support events for individuals with Gitelman/Bartter Syndromes and their families: participant feedback and reflections.            

Susana  Borja-Boluda     

Cambridge University Hospitals - Addenbrookes

 

P051      The Role of Early Dietary Advice in the Modification of Health Beliefs and Behaviours amongst Haemodialysis Patients

David Charles    

Barts and the London School of Medicine and Dentistry

 

P052      Improving immunosuppression dosing in renal transplant recipients-An MDT approach   

Rajkumar Chinnadurai   

Salford Royal NHS Foundation Trust

 

P053      Renal Medicine Recruitment Challenge – The UK experience       

Alvin Karangizi  

Worcestershire Royal Hospital

 

P054      Development of low potassium dietary resources for a multi-ethnic population. 

Deepa Kariyawasam      

Department Of Dietetics, King's College Hospital

 

P055      Acute Kidney Injury (AKI) training and confidence amongst Medical and Nursing Students:  Do they feel well prepared to identify and manage AKI?   

Jonathan Murray             

South Tees NHS Foundation Trust

 

P056      Fatigue in prevalent hemodialysis patients predicts all-cause mortality and kidney transplantation

Federica Picariello

King's College London

 

P057      Art and Craft Activities During Haemodialysis – an untapped potential to improve patients’ treatment experience.

Hugh Rayner     

Heart of England NHS Foundation Trust

 

P058      Quality improvement in parathyroidectomy outcome – a MDT approach

Varuni   Senanayake      

Heart of England NHS Foundation Trust

 

P059      Periscope: A Novel Tool to Enhance Learning through Social Media

Sivakumar Sridharan      

Lister Hospital

 

P060      Interprofessional simulation training for the management of medical emergencies on the haemodialysis unit: Results at ten months following implementation of the programme.

Kathryn Watson

Kings College London Hospital NHS Trust

 

Group 7: Clinical - Service Delivery, Quality & Innovation

Moderated by Clara Day and Ken Farrington

 

P061      New frontiers: establishing an outpatient Occupational Therapy service on a dialysis unit

Lisa Ancliffe

Guy's and St Thomas' NHS Foundation Trust

 

P062      Engaging staff to deliver Shared Care by educating and implementing tools to close down perceived barriers through team work

Jyoti Baharani   

Heart Of England Foundation Trust

 

P063      Improving permanent access in Haemodialysis patients - an RCA based approach 

Jyoti       Baharani

Heart of England Foundation Trust

 

P064      Delivering Sustainable Growth of a Home Haemodialysis Programme      

Hannah Beckwith            

Imperial College

 

P065      Improving Communication with Haemodialysis Patients who are Hard of Hearing

Caryss   Cox       

Derby Teaching Hospitals NHS Foundation Trust

 

P066      Dialysis in Secure Environments: Redesigning Health Policy for Prisoners with Kidney Disease

Partha Das         

Harvard University/NHS England

 

P067      Implementation of a Haemodialysis Patient Safety Index to monitor Common Adverse Events and drive Quality Improvement   

Katie Fielding    

Derby Teaching Hospitals NHS Foundation Trust / UK Renal Registry

 

P068      Chronic Kidney Disease - Shared Care Pathway: Follow Up At One Year

Kavita Gulati      

Imperial College NHS Trust

 

P069      All on broad: A person centred, holistic approach to providing diabetes care to haemodialysis patients    

Samantha Jennings        

BHSCT

 

P070      An evaluation of volume status assessment in acute kidney injury: a quality improvement project.

Adam Mounce 

Cardiff University School of Medicine

 

P071      A Multidisciplinary Renal Genetics Clinic – Model for our Times

Caroline Robinson          

Cambridge University Hospitals NHS Foundation Trust

 

P072      The origins of UK renal clinical computing 1980-1994       

Eric Will               

Ex Leeds Teaching Hospitals

 

Group 8: Clinical -  Transplantation

Moderated by James Pattison and Lisa Burnapp

 

P074      HLA-DQ eplet mismatches are not associated with survival outcomes and graft function in renal transplant recipients           

Vicky Brocklebank          

Newcastle University

 

P075      Do pre-transplant therapeutic drug monitoring trials predict calcineurin inhibitor dose accurately in HIV-infected patients undergoing kidney transplantation?

Stephanie Chong             

Royal London Hospital

 

P076      Delisting ‘unacceptable’ donor specific antibodies that correlate with a negative flow cytometric crossmatch facilitates transplanting highly sensitized, long waiting patients on the transplant waiting list – outcomes from a single UK transplant centre.    

Andrew Connor

South West Transplant Centre, Derriford Hospital, Plymouth

 

P078      Epstein – Barr Virus Infection in Adult Kidney Transplant Recipients.        

Catherine Johnson         

Derby Teaching Hospitals

 

P079      Enteric hyperoxaluria secondary to pancreatic insufficiency – an unusual cause of renal allograft dysfunction               

Sabina   Karimi  

Addenbrookes Hospital

 

P082      6 Years of Living Kidney Donor Transplantation in Teesside: A Prospective Review             

Sarah Manning 

James Cook University Hospital

 

P083      Dialysis After Renal Allograft Loss – Data from a Non-Transplanting Renal Centre

Khai Ping Ng      

Birmingham Heartlands Hospital

 

P084      BK Virus Associated Nephropathy in Renal Transplant Recipients a Single Centre Experience         

Ghulam Rana     

Sheffield Kidney Institute, Sheffield Teaching Hospitals NHSFT

 

P085      Determinants of BK Viraemia Duration and Risk for Nephropathy: A Single Centre Study

Michael Turner

University of Oxford

 

P086      Telephone clinic for renal transplant recipients – patient co-designed quality improvement project

Udaya   Udayaraj             

North Bristol NHS Trust

 

Group 9: Clinical -  Transplantation

Moderated by Neil Sheerin and Caroline Wroe

 

P087      Outcomes of augmented immunosuppressive protocol to prevent recurrent FSGS in high risk kidney transplant recipients      

Yasser Ashraf    

St James Hospital Leeds

 

P088      Long term outcomes in living kidney donors at a single UK transplant centre

Yousef Deen     

St George's, University Of London

 

P089      Benefits of a Cardio-Renal Multi-Disciplinary Team Meeting to Manage High Cardiac Risk Patients on Kidney Transplantation Waitlist

Maria Fernandez             

St George's University Hospital NHS Foundation Trust

 

P090      What is the Optimal Initial Tacrolimus Dose in Black Renal Transplant Recipients?              

Katie Hughes    

St. George's Hospital NHS Foundation Trust, London, UK

 

P091      LACK OF DISPARITY IN RENAL LENGTH IS NOT A RELIABLE GUIDE TO NORMAL DIFFERENTIAL RENAL FUNCTION IN POTENTIAL KIDNEY DONORS

Edward Kingdon              

Sussex Kidney Unit

 

P092      A single centre retrospective study of CMV prophylaxis with valganciclovir in de novo renal transplant recipients

Amy Page           

University Hospitals of Leicester

 

P093      REPATRIATION OF IMMUNOSUPRESSIVE DRUGS IN KIDNEY TRANSPLANT RECIPIENTS AT A LARGE TRANSPLANT CENTRE

Shazia Shabir     

University Hospitals Birmingham NHS Foundation Trust

 

P094      CLINIC NON-ATTENDANCE WITHIN THE FIRST YEAR POST KIDNEY TRANSPLANTATION IS ASSOCIATED WITH REJECTION, GRAFT DYSFUNCTION AND DEATH-CENSORED GRAFT LOSS  

Adnan Sharif     

Queen Elizabeth Hospital

 

P095      DISTANCE OF PATIENT RESIDENCE FROM KIDNEY TRANSPLANT CENTER DOES NOT IMPACT UPON POST-TRANSPLANTATION OUTCOMES: A SINGLE-CENTER ANALYSIS     

Adnan Sharif     

Queen Elizabeth Hospital

 

P096      NEUTROPHIL-TO-LYMPHOCYTE RATIO (NLR) CHANGE IN THE FIRST WEEK POST KIDNEY TRANSPLANTATION IS ASSOCIATED WITH INCREASED RISK FOR DEATH-CENSORED GRAFT LOSS

Adnan Sharif     

Queen Elizabeth Hospital

 

P097      PRE-OPERATIVE ALBUMIN IS PREDICTIVE OF INCREASED LENGTH OF STAY AND OVERALL GRAFT LOSS AFTER KIDNEY TRANSPLANTATION       

Adnan Sharif     

Queen Elizabeth Hospital

 

P098      ARE OUTCOMES FOR BLACK KIDNEY TRANSPLANT RECIPIENTS INFERIOR TO OTHER ETHNIC GROUPS? A SINGLE-CENTRE ANALYSIS OF RECORD LINKED DATA

Adnan Sharif     

Queen Elizabeth Hospital

 

P099      COMPARING GLYCAEMIC BENEFITS OF ACTIVE VERSUS PASSIVE LIFESTYLE INTERVENTION IN KIDNEY ALLOGRAFT RECIPIENTS (CAVIAR): AN OVERVIEW AND UPDATE OF STUDY RECRUITMENT

Adnan Sharif     

Queen Elizabeth Hospital

 

P100      BASELINE DEMOGRAPHICS AND OUTCOMES FOR KIDNEY TRANSPLANT RECIPIENTS REFERRED INTERNALLY OR EXTERNALLY TO TRANSPLANT CENTRE FOR SURGERY

Adnan Sharif     

Queen Elizabeth Hospital

 

Group 10: Clinical -  CKD

Moderated by Stephanie Stringer and Elaine Rutherford

 

P102      CKD GP referrals Pre & Post NICE CKD guidelines 2014

Aruna  Arjunan

Dorset County Hospital, Dorset

 

P103      Progression of early stage chronic kidney disease in older versus younger persons

Venkata R Latha Gullapudi          

Nottingham University

 

P105      HOSPITAL ADMISSIONS IN PERSONS WITH CHRONIC KIDNEY DISEASE STAGE 3

Natasha Mcintyre           

Graduate Entry School of Medicine, University Of Nottingham

 

P106      Establishing a clinical phenotype for cachexia in end-stage kidney disease

Clare Mckeaveney          

Queen's University Belfast

 

P108      Factors associated with unplanned dialysis start

Ademola Olaitan              

Royal London Hospital

 

P109      Progression of Albuminuria in Persons with Early Stage Chronic Kidney Disease

Maarten Taal     

Royal Derby Hospital

 

P110      A National Cohort Study to Facilitate Stratified Medicine in Chronic Kidney Disease

Maarten Taal     

Royal Derby Hospital

 

 Group 11: Clinical -  Diagnostic approaches & interventions, Clinical -  Infection control, Clinical -  Medicines Management/Pharmacy/Pharmacology, Clinical -  Service Delivery, Quality & Innovation

Moderated by Emma Vaux and Graham Warwick

 

P111      Perception and practice of renal pharmacists on drug dosing in chronic kidney disease patients- A UK-wide survey 

Jokha AL-Qassabi            

University Of Manchester

 

P112      RENAL BIOPSY COMPLICATION RATES AND TRANSFUSION REQUIREMENTS IN A TERTIARY TEACHING HOSPITAL

Sumoyee Basu 

Guys and St Thomas' Hospitals

 

P113      A Pharmacist and Nurse-led Repatriation with Tacrolimus Brand Switch

Rachel Fraser    

Newcastle Upon Tyne Hospitals

 

P115      Screening for latent TB in incident end-stage renal failure patients            

Katherine Hull   

University Hospitals of Leicester

 

P116      Medicines Safety in Haemodialysis (HD):  Taking Action to Ensure Medicines Governance Compliance, Staff Competence and Patient Safety When Non-Registered Practitioners Administer 0.9% Sodium Chloride (Normal Saline) on Dialysis          

Caroline Judge 

East Kent Hospitals NHS Foundation Trust

 

P117      Population Distribution of Haematocrit-Corrected Tacrolimus Concentrations in Renal Transplant Patients

Simon Mann     

Lancashire Teaching Hospitals NHS Foundation Trust

 

P118      The safety of prescribing apixaban in patients with end stage renal disease on haemodialysis: a single centre's experience        

Jonathan Noble

Gloucestershire Hospitals NHS Foundation Trust

 

P120      Renal Biopsies-A single centre review of complication rates         

Reem Taha         

Sunderland Royal Hospital

 

P121      Blood pressure control in early stage CKD without diabetes: are we undertreating hypertension?

Helen Wheeldon             

University of Birmingham Medical School

 

Group 12: Clinical - Vascular Access

Moderated by Marissa Dainton and Enric Vilar

 

P122      Incidence, Survival and Risk Factors for Central Venous Stenosis in Haemodialysis Patients

Anamika Adwaney         

Imperial College London

 

P123      THE PRIMARY PATENCY OF ARTERIOVENOUS FISTULAS – A SINGLE CENTRE AUDIT             

Monica Bowa- Nkhoma

Queen Elizabeth Hospital Birmingham

 

P124      FIBRIN SHEATH STRIPPING AND CATHETER EXCHANGE FOR FAILED TUNNELLED DIALYSIS CATHETERS        

Nick Fardon       

Sheffield Kidney Institute

 

P126      To what extent can we avoid starting haemodialysis on a central venous catheter?           

David Kent         

Hull York Medical School

 

P127      DOES SURVEILLANCE OF TRANSONIC FLOW IN VASCULAR ACCESS PREDICT INCREASED RISK OF ACCESS LOSS?               

Uwadiegwu Wilfred Okoroafor 

Royal Devon and Exeter NHS Foundation Trust

 

P128      Does timely creation of Arteriovenous fistula (AVF) influence the rate of decline of kidney function?         

Sivaramakrishnan Ramanarayanan          

Lister Hospital, East and North Hertfordshire trust

 

P129      Primary failure rate of arterio-venous fistulae: Influence of surgical factors

Sivaramakrishnan Ramanarayanan          

Lister Hospital, East and North Hertfordshire trust

 

P130      An analysis of factors predicting the outcome after radiological intervention in arteriovenous fistulas

Michael Robson

King's College London

 

P131      Prevention of staphylococcus aureus bacteraemia in haemodialysis patients

Tamasin Stevenson        

Heart of England NHS Trust

 

P132      Arteriovenous fistula use and patency in a contemporary haemodialysis population: a national observational study

Sokratis  Stoumpos        

University Of Glasgow

 

P133      Online Haemodialysis Arteriovenous Fistula Surveillance               

Ahsan Syed        

Hull & East Yorkshire Hospitals NHS Trust

 

Group 13- Clinical -  Peritoneal Dialysis

Moderated by Ramzana Asghar and Jayne Woodhouse

 

P134      Review of the effectiveness of Chloraprep as a cleansing agent for exit site care

Toots Ansell      

Wessex Kidney Unit, Portsmouth Hospital Trust

 

P135      Assisted Automated Peritoneal Dialysis (AAPD)- A Unit Experience           

Ramzana Asghar

Lancashire Teaching Hospitals NHS Foundation Trust

 

P136      Recurrent Peritoneal Dialysis Exit Site Infections: Incidence, Causative Organisms and Clinical Outcomes

Hannah Beckwith

Imperial College

 

P137      SUCCESSFUL ADOPTION OF REMOTE MANAGEMENT AND MONITORING TO SUPPORT PATIENTS ON AUTOMATED PERITONEAL DIALYSIS.      

Monica Bowa- Nkhoma

Queen Elizabeth Hospital Birmingham

 

P138      Pets and PD: A Case Series          

Victoria Carnall 

Royal Devon and Exeter Foundation Trust

 

P139      Two CAPD exchanges per day – an approach to provide individualised dialysis support for elderly and frail patients with a positive outcome             

Titus Chelapurath            

Imperial College Healthcare NHS Trust

 

P140      U Drain in peritoneal dialysis pilot study: 15 patient experience and outcomes

David     Lewis    

Salford Royal Foundation NHS Trust

 

P141      Residual renal function as a predictor of PD peritonitis   

Arunraj Navaratnarajah

Imperial College NHS Healthcare Trust

 

P142      Peritoneal dialysis can be safely prescribed with days off: Analysis of technique survival

Arunraj Navaratnarajah

Imperial College NHS Healthcare Trust

 

P143      Peritoneal dialysis related infections according to BMI in patients with Tenckhoff catheter inserted with the Seldinger technique       

Vivienne Ralph 

King's College Hospital, London

 

P144      Dialysis Adequacy, Weight Gain and Development of Diabetes in Patients with a BMI of 30 or above receiving Peritoneal Dialysis

Vivienne Ralph 

King's College Hospital, London

 

P145      Effect of Peritoneal Dialysis on the 24-hour Glycaemic Profile of Non-diabetic Patients

Jennifer Williams             

University Of Exeter

 

Group 14: Clinical -  Paediatric Nephrology, Clinical -  Transitional Care and Clinical -  Miscellaneous

Moderated by Sally Johnson and David Hughes

 

P148      Talking about sex: The Challenge to Holistic Care              

Maxine Hough  

Royal Devon and Exeter NHS Trust

 

P149      Transition via the antenatal clinic: a case report

Heather Lambert             

Newcastle upon Tyne Hospitals Trust

 

P150      ‘Kidney School' the 21st Century Armchair Classroom – a Model for Peer Supported Learning Using Teleconferencing Technology   

Amanda Newnham        

Leeds Children's Hospital

 

P151      Ofatumumab, a safe alternative in Rituximab allergic patients, for treatment of FSGS recurrence post Renal Transplantation

Amanda Newnham        

Leeds Children's hospital

 

P153      Delay to Diagnosis in Multiple Myeloma

Ritika Rana

UHB, Birmingham

 

P154      Improvement in health and social outcomes of a young adult with CKD with holistic support by the young adult service:  A case report       

Helen Ritson      

Newcastle-upon-tyne NHS Trust

 

P155      Haemodiafiltration is associated with reduced inflammation and oxidative stress and improved endothelial risk profile compared to high-flux haemodialysis in children

Rukshana Shroff              

Great Ormond Street Hospital NHS Foundation Trust

 

P156      Modification of Young Adult Outcomes on Haemodialysis-Changing ‘’Our’’ Practice          

Marie-Louise Turner      

St George's Hospital NHS Foundation Trust

 

P157      Paediatric Dialysis Access Complications in the UK            

Patrick Walsh   

Newcastle University

 

Group 15: Clinical – Nutrition

Moderated by Helen Mclaughlin and TBC

 

P158      Too much of a good thing: hypervitaminosis A and unexplained weight loss in a bariatric surgery dialysis patient.

Deepa   Kariyawasam    

Department Of Dietetics, King's College Hospital

 

P159      Renal Dietetic Input In Patients Before Starting Dialysis  

Jessica  Budd    

Nottingham University Hospitals

 

P160      MALNUTRITION RISK FACTORS AND DIETARY INTERVENTION IN PATIENTS ATTENDING AN ADVANCED KIDNEY CARE CLINIC      

Jade Harrison    

St George's Hospital

 

P161      Dialysis-free survival time in older people with advanced chronic kidney disease with enhanced dietetic interventions v standard care: a 2 year randomised pilot study.  

Lina Johansson

Imperial College Healthcare NHS Trust

 

P162      Adherence to salt and fluid limitation in the haemodialysis population    

Zoe Kantor

Lister Hospital

 

P164      The combination of Bioimpedance and PROMs in the Nutritional assessment of a Haemodialysis cohort

Ying Kuan           

Altnagelvin Hospital

 

P165      The use of handgrip strength as a screening tool to determine a more timely dietetic review of haemodialysis patients at risk of malnutrition.

Catharine Noble              

Northern General Hospital

 

P166      A Service Evaluation on the Impact of Group Education on Salt Consumption and Nutritional Knowledge in Patients with CKD Stages 3-5

Raina O'Mahony              

Gloucestershire Hospitals NHS Foundation Trust

 

P167      Renal dietary information: Are haemodialysis patients receiving what they need?             

Tanuja Quinn    

North Bristol NHS Trust

 

P168      Factors associated with temporal changes in skin autofluorescence in dialysis patients

Daniela Viramontes Horner        

Centre for Kidney Research and Innovation, Faculty of Medicine and Health Sciences, University of Nottingham

 

P169      The effect of changing from hospital to home haemodialysis on nutrition parameters: a pilot        

Rachel Wormell

Churchill Hospital

 

Group 16: Clinical - Renal Rehabilitation & Exercise

Moderated by Vicky Pursey and Pelagia Koufaki

 

P170      A feasibility study investigating the impact of implementing an aerobic exercise programme on a Haemodialysis satellite unit.       

Manasi Desai    

Royal Free London NHS Foundation Trust

 

P171      The association of physical function and physical activity with all-cause mortality and adverse clinical outcomes in non-dialysis chronic kidney disease and renal transplant recipients: a systematic review.

Heather Mackinnon       

University Of Leicester

 

P172      A NOVEL MEANS TO ASSESS POSTURAL INSTABILITY IN CHRONIC KIDNEY DISEASE: COMPARISON WITH A HEALTHY CONTROL COHORT      

Daniel Nixon     

University Of Leicester

 

P173      Perceptions of skeletal muscle wasting are negatively associated with physical activity and physical function in patients with chronic kidney disease      

Tom O'Sullivan 

University Of Leicester

 

P174      A review of the literature relating to exercise interventions in dialysis patients on both medical and quality of life outcomes

Joanna Pulman

Dorset County Hospital NHS Foundation Trust

 

P175      Characteristics of Haemodialysis Patients with Higher Levels of Physical Activity: Are More Active Patients Under-dialysed?             

Sivakumar Sridharan      

Lister Hospital

 

P176      Utility of Accelerometer and Physical Activity Questionnaire for estimating Habitual Activity in Patients with Kidney Disease 

Sivakumar Sridharan      

Lister Hospital

 

P177      Physical Capacity and Exercise Patterns in Patients with End Stage Renal Disease

Fiona Willingham             

Derby Teaching Hospitals NHS Foundation Trust

 

P178      Pre-Emptive Rehabilitation to Prevent Dialysis Associated Morbidity (PREHAB): Baseline and 3-Month Follow-Up Data               

Fiona Willingham             

Derby Teaching Hospitals NHS Foundation Trust

 

P179      A cross-sectional investigation into the impact of frailty in people on maintenance haemodialysis              

Tobia Zanotto   

Queen Margaret University

 

Group 17: Clinical -  Tubular Disorders and Clinical - Rare Renal Disorders

Moderated by Kate Bramham and TBC

 

P180      The side effect profile of mTOR inhibitors used as monotherapy in Tuberous Sclerosis Complex (TSC)

Nicholas Annear              

St George's University of London

 

P181      Two cases of Pregnancy in Patients with Cystinosis          

Hannah Blakey  

Queen Elizabeth Hospital Birmingham

 

P182      Simultaneous sequencing of 37 genes identifies causative mutations in the majority of children with renal tubulopathies   

Detlef Bockenhauer       

UCL Centre for Nephrology/Great Ormond Street Hospital

 

P183      Disease progression in UMOD nephropathy - a deep phenotyping longitudinal study.

Susana  Borja-boluda     

Cambridge University Hospitals-addenbrookes

 

P184      Risk Factors for Severe Renal Disease in Bardet-Biedl Syndrome 

Sarah Borrows  

University Hospitals Birmingham

 

P185      The Spectrum of Presentation of Renal Infarction: Fives cases from one centre and a review of the literature               

Jack Burnham   

Gloucestershire Hospitals NHS Foundation Trust

 

P186      Tuberous Sclerosis: Clinical Characteristics and MDT approach in management

Rajkumar Chinnadurai   

Salford Royal NHS Foundation Trust

 

P187      Impact of citrate supplementation on metabolic parameters in Swiss recurrent calcium stone formers     

Nilufar Mohebbi              

University Hospital Zurich

 

P188      Urinary retinal binding protein in untreated systemic immunoglobulin light chain amyloidosis at baseline.

Tamer Rezk       

UCL Division of Medicine

 

P189      A Pathogenic Variant in the alternative complement pathway in a patient with Bone Marrow Transplant associated Thrombotic Microangiopathy.

Patrick Walsh    

Newcastle University

 

Group 18: Laboratory Science -  Acute Kidney Injury, Laboratory Science -  Endothelial and vascular pathobiology, Laboratory Science -  Developmental biology, Laboratory Science -  Leukocyte Biology, Laboratory Science -  Mediators, biomarkers, receptors and signalling pathway, Laboratory Science - Genetic Disorders, Laboratory Science - Rare Renal Disorders

Moderated by Jill Norman and David Gardner

 

P191      Sodium chloride promotes pro-inflammatory T cell populations in patients with autoimmune kidney disease, an effect that is not prevented by sodium transport inhibition

Rhys Evans         

Ucl Centre for Nephrology

 

P192      REAL-TIME MICROENVIRONMENT OF THE ISCHEMIA-REPERFUSED PORCINE KIDNEY

David Gardner  

University Of Nottingham

 

P194      Low dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells

Akimichi Inaba  

University Of Cambridge

 

P195      K-Cadherin Protein is a Novel Basalolateral Sensor Involved in the Trans-Nephron Signalling for BMP-7 Release

Kameljit Kalsi     

South West Thames Institute for Renal Research

 

P196      The genetic and molecular defects in severe bladder malformations in the T30H experimental model

Natalie  Milmoe

UCL

 

P197      A new genetic cause of renal tubular acidosis

John Sayer         

Newcastle University

 

P198      Investigation of inherited renal disease: Human Urine Derived Renal Epithelial cells provide insights into kidney specific alternate splicing mutations         

John Sayer

Newcastle University

 

P200      Vitamin D Supplementation induces myogenic differentiation in skeletal muscle cells isolated from Vitamin D deficient patients.          

Emma Watson

University of Leicester

 

P201      The effects of maternal smoking and BMI on the first and second trimester human fetal kidney

Heather M Wilson           

University of Aberdeen

 

P202      Renoprotection of CHBP against Ischemia Reperfusion­related Renal Injury with or without Cyclosporine A Nephrotoxicity Associated with Improving Endoplasmic Reticulum Stress

Bin Yang              

University of Leicester

 

Group 19: Laboratory Science -  Renal Physiology, Laboratory Science -  Renal Stones, Laboratory Science -  Systemic Vasculitis, Laboratory Science -  Transplantation, Laboratory Science -  Tubular cell pathobiology, Laboratory Science – Biomarkers, Laboratory Science - Proteomics/Genomics/Metabolomics, Laboratory Science - Regenerative Medicine

Moderated by Ruth Pepper and Mark Dockrell

 

P203      Electrochemical detection of urinary microRNAs as renal disease biomarkers

Timothy Bowen

Cardiff University

 

P204      Are there good and bad kidneys? A transcriptional approach

John Ferdinand

University Of Cambridge

 

P205      Using antisense oligonucleotides to target mutant uromodulin: therapeutic poof-of-principle.

Fiona Karet        

University of Cambridge

 

P206      Adipose-derived regenerative cells: therapeutic potential in renal ischaemia reperfusion injury

Rashida Lathan 

University of Glasgow

 

P207      Tacrolimus and creatinine analysis by LC-MS/MS using Mitra® microsampling devices

David Marshall

Wythenshawe Hospital, Manchester University NHS Foundation Trust

 

P208      Integrative Analysis of Genome-Wide Transcriptome Data Sets Reveals Shared Biology Between Lupus and its Co-Morbidities 

Thomas Oates

Barts Health NHS Trust

 

P209      Physiological and Dietary Differences in Stone Formers

Benjamin Oliveira            

Royal Free Hospital

 

P210      Spleen tyrosine kinase expression in human neutrophils in AAV

Maria Prendecki              

Imperial College

 

P211      Characterising the effects of cystinuria causing missense mutations M467T, G458A and T471R on cystine transport system b(0,+) in a human proximal tubule cell line using automated fluorescent microscopy

Sebastian Wild  

Bristol University

 

P212      HBSP protected against Renal Ischemia Reperfusion Injury in a Mouse Model with or without Properdin Deficiency

Yuanyuan Wu   

University Of Leicester

 

P213      Canonical vitamin A signalling in collecting duct cells controls expression of anti-fibrotic microRNAs and is differentially regulated by AKI/CKD mediators    

Qihe Xu

King's College London

 

P214      Renal collecting ducts: A frontline in protecting against tubulointerstitial injury?

Qihe Xu

King's College London

 

THURSDAY MODERATED POSTERS

 

Group 20: Case Reports

Moderated by Janice Harper and Matt Hall

 

P215      A rare association with anti-GBM disease             

Helena  Edwards              

Portsmouth Hospitals NHS Trust

 

P216      A successful pregnancy in a patient following renal transplantation for atypical HUS managed with eculizumab

Chee Cheung

University Hospitals of Leicester NHS Trust

 

P217      Granulomatous Tubulointerstitial Nephritis with Vasculitis           

James  De Boisanger      

Imperial College Healthcare NHS Trust

 

P218      A rare presentation of seizures, memory loss and nephrotic syndrome   

Dimitrios Chanouzas      

University Hospital Birmingham / University of Birmingham

 

P219      Fracture of an internal jugular haemodialysis catheter secondary to material fatigue        

Ruth Fergie        

South Eastern Health and Social Care Trust

 

P220      Non-dilated obstruction with tubulo-interstitial nephritis: a diagnostic challenge

Sally Hamour

UCL Centre For Nephrology

 

P221      A case of bile salt malabsorption with CMV infection causing kidney transplant failure     

Mustakim Khandaker    

Royal Liverpool University Hospital

 

P222      Vancomycin Toxicity Successfully Treated with Haemodiafiltration

Aaron    Lake

Ulster Hospital

 

P223      Parvovirus B19 causing anaemia and pancytopenia post renal transplantation: Report of 2 cases

Rob Parry           

Royal Cornwall Hospitals Trust

 

P224      Long term management of a family with Calcium –sensing receptor mutation

John Sayer         

Newcastle University

 

P225      A case of Minimal Change Glomerulonephritis with two acute neurological presentations              

Arvind Singh

Gloucestershire Royal Hospital

 

P226      Two different ‘points’ of view: A case report of two different pathologies, crescentic IgA nephropathy and acute tubulointerstitial nephritis, developing after treatment with an immune checkpoint inhibitor           

Madelena Stauss             

Royal Preston Hospital

 

Group 21: Clinical -  Acute Kidney Injury

Moderated by Nick Selby and Damien Ashby

 

P227      One year outcomes following Acute Kidney Injury (AKI): influences of prescribing patterns

Aleli Akani

Royal Derby Hospital

 

P228      Use of urine output for detection of AKI in intensive care units and cardiac surgery

Jennifer Allen     

Nottingham University Hospitals NHS Trust

 

P229      Acute Kidney Injury after Post Partum Haemorrhage       

Manuela Amaya

North Bristol NHS Trust

 

P230      Reducing AKI in patients undergoing orthopaedic surgery through the introduction of an AKI predictive tool.

David Baird        

NHS Tayside

 

P231      Development, implementation and audit of a medicines optimisation tool for AKI: a pilot study within a single acute NHS trust

Paul Clarke         

Oxford University Hospitals NHS Foundation Trust

 

P232      A RISK SCORE FOR HOSPITAL ACQUIRED ACUTE KIDNEY INJURY (H-AKI) IN PATIENTS ADMITTED TO HOSPITAL AS A MEDICAL EMERGENCY: SINGLE CENTRE OBSERVATIONAL STUDY

Steve Dickinson

Royal Cornwall Hospitals NHS Trust

 

P233      HOSPITAL RE-ADMISSIONS PATTERNS IN THE FIRST YEAR AFTER AN EPISODE OF ACUTE KIDNEY INJURY: RESULTS FROM THE PROSPECTIVE PARALLEL COHORT STUDY      

Venkata R Latha Gullapudi

Nottingham University

 

P234      Patterns and prevalence of albuminuria one year following episode of Acute Kidney Injury: Results from prospective parallel cohort study

Venkata R Latha Gullapudi          

Nottingham University

 

P235      QI projects and AKI responses: Can stickers ever be as effective as electronic recording of interventions?  A review of an AKI care bundle intervention programme.  

Hannah Jenkins

Royal Devon and Exeter Hospital

 

P236      Is Frailty a Predictor of Outcomes in Elderly Inpatients with AKI? A Prospective Cohort Study

Sarah Morton

St George's Hospital

 

P237      Does an Acute Kidney Injury Care Bundle improve Management?             

Victoria Weir     

NHS Grampian

 

P238      Assessing quality of care for Acute Medical patients with Acute Kidney Injury (AKI) at St George’s Hospital – closing an evolving loop

Robert  Yates    

St George's University of London

 

P239      HELPING PARENTS AND GRANDPARENTS WITH CHRONIC KIDNEY DISEASE TALK TO THEIR CHILDREN/GRANDCHILDREN:  AN EXPLORATION OF COMMUNICATION AND NEED FOR SUPPORT RESOURCES

Heather Buchanan          

University Of Nottingham

 

Group 22: Clinical - Psychosocial Aspects

Moderated by TBC

 

P240      Developing an Arts-Based Intervention for Patients who have End-Stage Kidney Disease whilst receiving Haemodialysis: A study protocol

Claire Carswell  

Queen's University Belfast

 

P241      Curiosities and Conversations - A collaborative project between dialysis centre and local museums           

Claire Joyce       

Cambridge University Hospitals

 

P242      A baseline review of end of life discussions and decisions with haemodialysis patients     

Mustakim Khandaker    

Royal Liverpool University Hospital

 

P243      Understanding the needs of patients on hospital haemodialysis whose behaviour can be experienced as ‘challenging’ by staff teams

Janette Moran 

Leeds Teaching Hospitals NHS Trust

 

P244      Diagnostic Accuracy of Frailty Screening Methods in Chronic Kidney Disease

Andrew Nixon   

Lancashire Teaching Hospitals NHS Foundation Trust

 

P247      Exploring peoples’ experiences of being a parent with End Stage Renal Disease receiving haemodialysis treatment: A qualitative Study

Maria Tziggili     

Barts Health NHS Trust and City University London

 

P248      Mood Disturbance in Kidney Transplant Recipients: Prevalence and Predictors.

Aimee   Williams              

UHB

 

Group 23: Clinical -  MDT Education / research, Clinical - Patient Reported Outcomes and Experience Measures (PROMS & PREMs)/Quality of Life

Moderated by Mary Dutton and Nicola Anderson

 

P249      A qualitative study of patients’ and clinicians’ perspectives on the use of electronic Patient-Reported Outcome measures (ePROMs) in the management of patients with Advanced Chronic Kidney Disease (PRO-trACK Project)

Olalekan Lee Aiyegbusi 

University of Birmingham

 

P250      Development and usability testing of a web-based electronic patient-reported outcome measure (ePROM) system for patients with advanced chronic kidney disease

Olalekan Lee Aiyegbusi 

University Of Birmingham

 

P251      Occupational Therapy in renal: a call to arms!

Lisa Ancliffe

Guy's and St Thomas' NHS Foundation Trust

 

P252      Embedding PROMS into routine haemodialysis unit use - the role of staff engagement

Jyoti Baharani   

Heart of England Foundation Trust

 

P253      Developing a person-centred approach to care in a dialysis unit – the role of Patient Activation and Quality of Life measures

Jyoti Baharani   

Heart of England Foundation Trust

 

P254      Hope for the best, prepare for the worst: the development of a multidisciplinary haemodialysis emergencies simulation training program       

Matthew Bottomley      

Churchill Hospital, Oxford

 

P255      Patient Engagement in the Renal Transplant Clinic

Rachel   Fraser  

Newcastle Upon Tyne Hospitals

 

P256      A COMPARISON OF PATIENT ACTIVATION IN RENAL TRANSPLANT RECIPIENTS AND HAEMODIALYSIS PATIENTS

Rachel   Fraser  

Newcastle Upon Tyne Hospitals

 

P258      Survey of Self Assessed Quality of Life in a Haemodialysis Population: Opportunities for Care

Ying Kuan           

Altnagelvin Hospital

 

P259      SOLITUDE - Examining perceived benefits of reflexology in patients undergoing hospital based haemodialysis - study protocol.

Michael Matthews          

Northern Health and Social Care Trust

 

P260      A cross-sectional analysis of patient activation measures in pre-dialysis and centre-based haemodialysis

Veena Reddy

Sheffield Kidney Institute

 

Group 24: Clinical -  Patient education/involvement and experience

Moderated by Tess Harris and Nicola Anderson

 

P261      Waitlisted for transplantation: getting the right messages across at the right time              

Wendy Brown  

Imperial College Healthcare Trust

 

P262      Outcomes of a modified diabetes structured education programme for chronic kidney disease

Nevine El-sherbini          

Imperial College Healthcare NHS Trust

 

P263      Implementing a national adult Patient Reported Experience Measure (PREM) for kidney patients

Rachel   Gair       

UK Renal Registry

 

P264      Self-reported adherence with treatment: renal patients with Lupus and Vasculitis in a multi-ethnic urban cohort  

Sally Hamour    

UCL Centre for Nephrology

 

P265      Patient reported outcomes and experience in ANCA associated vasculitis  - themes and gaps

Peter Rutherford            

Vifor Pharma

 

P266      Empowering patients to be in control through Shared Haemodialysis Care

Helen Spooner 

New Cross Hospital Wolverhampton

 

P267      Increasing employability and work opportunities for people managing chronic kidney disease: Digital Skills Pilot Project (CKD-DiSk)

Cristina Vasilica

University of Salford

 

P268      Effects of a one-month dietitian-led fluid awareness campaign on interdialytic weight gain            

Jenny Ward       

University Hospitals Coventry & Warwickshire NHS Trust

 

P269      'Know your kidneys' - An evaluation of an educational seminar for patients with Chronic Kidney Disease stage 3.           

Helen Watts      

Imperial College Healthcare NHS Trust

 

P270      Developing the Yorkshire Dialysis vs Conservative management Decision Aid (YoDCA) intervention to enable renal professionals support patients making choices about conservative management.

Anna Winterbottom      

Leeds Teaching Hospitals Trust

 

P271      Implementation of a successful re-education programme for patients on peritoneal dialysis (PD) resulting in improved PD peritonitis rates    

Jayne Woodhouse          

Oxford University Hospitals NHS Foundation Trust

 

Group 25- Clinical -  Service Delivery, Quality & Innovation

Moderated by Lynne Sykes and TBC

P272      Successful provision of haemodialysis within the prison environment

Clara      Day       

Queen Elizabeth Hospital Birmingham

 

P273      West Midlands Renal Peer Review: outcome based and focused around peer learning

Clara      Day       

Queen Elizabeth Hospital Birmingham

 

P275      An Audit of the Management of Pyelonephritis at a District General Hospital

Samitha Fernando          

Princess Royal University Hospital

 

P276      DNACPR Decisions in Stand-Alone Satellite Haemodialysis Units

Reena Popat     

Lister Hospital ENHT

 

P277      Royal Preston Hospital Renal Vascular Access Service Quality Improvement Programme

Beng So

Royal Preston Hospital

 

P278      Transitions between modalities: a single centre retrospective study in an incident cohort of dialysis patients

Kylie Jones         

Royal Derby Hospital

 

P279      Immediate Discharge Letter (IDL) Quality Improvement Project

Laura Martin     

Queen Elizabeth University Hospital

 

P280      Peritoneal Dialysis Catheter Medical Insertion Service establishment and Redesign

Arvind Ponnusamy         

Royal Preston Hospital

 

P281      Developing a specialist polycystic kidney disease clinic: one years experience at King’s College Hospital

Kathryn Griffiths              

King's College Hospital Trust

 

P282      What is a Chief Registrar and do we need our Nephrology Trainees to embrace this opportunity?

Helena  Edwards              

Portsmouth Hospitals NHS Trust

 

P283      Improving patient safety during inter-hospital transfers by implementation of a transfer policy

Helena Edwards               

Portsmouth Hospitals NHS Trust

 

P284      Home Therapies Service Redesign

Tracy Jefferies

Lancashire Teaching Hospitals NHS Foundation Trust

 

Group 26. - Clinical -  Service Delivery, Quality & Innovation

Moderated by Clare Castledine and Paul Rylance

 

P285      Increasing uptake of Peritoneal Dialysis by holding a Rapid Improvement Event

Richard Baines  

University Hospitals of Leicester NHS Trust

 

P286      A quality improvement project to reduce non-attendance to renal outpatient clinics In the Wessex Kidney Centre 

Natalie  Borman

Wessex Kidney Centre

 

P287      Routine Collection of Patient Reported Outcome Measures and Renal Unit Cultural Characteristics

Rachel   Gair       

UK Renal Registry

 

P288      Working Towards Greater Home Therapy Uptake Through Improved Patient Education

Andrew McClean            

Royal Stoke University Hospital

 

P289      A novel e-mail helpline service to support Acute Kidney Injury management by Primary Care Services:  Initial experience and impact

Jonathan Murray             

South Tees NHS Foundation Trust

 

P290      Development of a ‘PD Link Nurse’ Programme to support Peritoneal Dialysis Uptake

Julie Stinson      

University Hospitals of Leicester

 

P291      Reasons for the underreporting and undertreatment of chronic kidney disease-associated pruritus.

Sabine Van Der Veer      

University Of Manchester

 

P292      Development of a renal dietetic patient database to comply with Renal Association undernutrition screening guidelines

Jenny Ward       

University Hospitals Coventry & Warwickshire NHS Trust

 

P293      The role of the Advance Nurse Practitioner in Renal Transplantation and Out Patient Service Development.

Aimee Williams

UHB

 

P294      Introducing ‘’WHO Check Lists’’ to Improve Patient Outcomes & Reduce Risk of Post-Renal Biopsy Complications

Siaw Tsin Yong  

St Georges University Hospital

 

P295      The effect of the ASSIST-CKD programme on referrals and management of CKD patients on the Wirral

Neil Bailey

Wirral University Teaching Hospital

 

Group 27: Clinical -  CKD and Clinical -  Epidemiology & Public Health

Moderated by Shona Methven and Angharad Marks

 

P296      Unparalleled Decline in Kidney Function Amongst Apparently Healthy Young Adults at Risk of Mesoamerican Nephropathy: Population Based Evidence and Risk Factors

Ben Caplin          

UCL

 

P297      Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease

Anthony Fenton              

University Hospitals Birmingham NHS Foundation Trust

 

P298  Mortality in Dialysis Patients in Qatar: An Epidemiological Retrospective study

Abdullah Hamad              

Hamad General Hospital

 

P299 Longitudinal study of change in GFR and blood pressure: 259 healthy adults in 12 villages in Ghana between 2002 and 2014

Iain MacPhee   

St George's, University Of London

 

P300      Sleep Quality Negatively Impacts Quality of Life in Non-Dialysis Dependent Chronic Kidney Disease Patients               

Daniel Nixon     

University Of Leicester

 

P301      Epidemiology of Mucinous Tubular spindle cell renal carcinoma: a Population-based Study using the SEER Database

Aditya Pawar    

Mayo Clinic

 

P302      Periodontitis severity contributes to CKD and CKD progression through increased oxidative stress

Praveen Sharma              

University of Birmingham

 

P303      National aHUS Service Experience of Meningococcal Disease in Patients on Eculizumab in England

Angela Watt

Newcastle Upon Tyne Hospitals NHS Trust

 

P304      Investigating the Effect of Bariatric Surgery on Renal Function: A Retrospective Study      

Li Xin Charlene Yeo         

University of Manchester

 

P305      New presentation of lupus nephritis following treatment with interferon              

Mohammed Abdelmahamoud  

Freeman Hospital

 

Group 28: Clinical -  Glomerulonephritis (treatment and outcomes)

Moderated by Megan Griffith and Colin Geddes

 

P306      Effective Treatment with Rituximab for the Maintenance of Remission in Relapsing Steroid Responsive Minimal Change Disease in Adults. A Single Centre’s 6 year Experience

Yasser Al-Mula Abed     

Lister Renal Unit, East and North Hertfordshire NHS Trust

 

P308      Associations of renal function decline in Lupus Nephritis- A single centre experience of over 12 years

Rajkumar Chinnadurai   

Salford Royal NHS Foundation Trust

 

P311      Plasmapheresis, Rituximab and Low-Dose Cyclophosphamide for Remission Induction Therapy in Severe ANCA-associated Vasculitis         

Kavita Gulati      

Imperial College NHS Trust

 

P313      Single-dose Rituximab (RTX) for frequently-relapsing steroid-sensitive nephrotic syndrome in adults is associated with earlier relapse and higher cumulative steroid exposure.

Christopher Lawrence   

East and North Herts NHS Trust

 

P314      A centre’s 5-year experience of using rituximab for Idiopathic Membranous Nephropathy

Clare Morlidge 

East and North Herts NHS Trust

 

P315      Association of histopathological variants with outcomes in IgA Nephropathy

Adam Morris     

Salford Royal Hospital

 

P316      Distribution and presentation of anti-GBM disease in the Severn region

Iain Smith           

North Bristol Trust

 

P317      TWENTY YEARS OF LUPUS NEPHRITIS MANAGEMENT – EVALUATION OF A MULTI ETHNIC PATIENT COHORT TO IDENTIFY FACTORS AFFECTING OUTCOME

Hannah Wilson

Imperial College London

 

Group 29: Clinical -  Glomerulonephritis (treatment and outcomes), Clinical -  Systemic Vasculitis and Clinical - Haematological and malignant disorders

Moderated by Liz Lightstone and TBC

 

P318      A Quartet of ANCA associated glomerulonephritis and vasculitis cases with initial presentation of diarrheal illness; which often is missed.

Mansoor Ali       

Calderdale and Huddersfield Hospitals NHS Trust

 

P319      Defining the Frequency and Characteristics of Thrombotic Microangiopathy in an Unselected Population

Hannah Beckwith

Imperial College

 

P320      Management and Outcomes of patients with ANCA-associated vasculitis (AAV) with pulmonary haemorrhage rescued with Extracorporeal Membrane Oxygenation (ECMO) – a series of 5 cases

Ricky Bell            

University Hospitals Leicester

 

P321      An audit of ANCA testing in granulomatosis with polyangiitis and microscopic polyangiitis: beware of false negative immunoassay results  

Vicky Brocklebank          

Newcastle University

 

P322      Long term outcomes of patients with ANCA associated vasculitis – a single centre experience      

Venkata R Latha Gullapudi          

Sheffield Teaching Hospitals NHS Foundation Trust

 

P323      Don’t look and you won’t find: diagnostic difficulty in a single-centre retrospective review of IgG4-related renal disease    

Robert Kimmitt

Royal Devon and Exeter NHS Foundation Trust

 

P324      Monoclonal Gammopathy of Renal Significance: establishing a Renal–Haematology– Histopathology MGRS Working Group.               

Andreas Kousios              

West London Renal and Transplant Centre, Hammersmith Hospital, Imperial College NHS Trust

 

P325      Relapse Free Survival After withdrawal of Steroid in Maintenance Treatment of ANCA Vasculitis

Eirini Lioudaki   

St Helier Hospital

 

P326      Age Stratified Response to IV Cyclophosphamide for the treatment of ANCA associated vasculitis

Eirini Lioudaki   

St Helier Hospital

 

P328      Clinical Characteristics and outcomes of Pneumocystis jirovecii infection in patients with ANCA associated vasculitis & patients with Kidney transplants over period of 10 years at NHS Grampian    

El Hakem Metraiah         

Aberdeen Royal Infirmary

 

P329      Renal stone disease in patients with thalassaemia.           

Adam Misky      

Whittington Health NHS Trust

 

P330      OUTCOMES OF TREATMENT OF MYELOMA IN PATIENTS REQUIRING RENAL REPLACEMENT THERAPY – “REAL WORLD” SINGLE CENTRE EXPERIENCE    

Aruni Ratnayake              

Epsom and St Helier University Hospitals NHS Trust

 

P331      RENAL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA WHO REQUIRED RENAL REPLACEMENT THERAPY – A SINGLE CENTRE EXPERIENCE  

Aruni Ratnayake              

Epsom and St Helier University Hospitals NHS Trust

 

P332      A National Cohort Study to Facilitate Stratified Medicine in Idiopathic Nephrotic Syndrome

Moin Saleem    

University Of Bristol

 

P333      Interesting association between acute kidney injury and isolated tonsillitis            

Arvind Singh      

Gloucestershire Royal Hospital

 

P334      Non fatal PML after rituximab in a patient with GPA        

Lisa Willcocks    

Cambridge University Hospitals NHS Foundation Trust

 

Group 30: Clinical -  Haemodialysis

Moderated by Tarek Eldheni and Alison Brown

 

P335      Higher TSH level in HD patient is associated with increased erythropoietin resistance and interdialytic weight gain and reduced dialysis adequacy

Abdulla Al Sayyari            

King Saud Bin Abdulaziz University for Health Scienced

 

P336      Optimising glycaemic control in haemodialysis patients with diabetes: a single centre audit

Jennifer Allen     

Nottingham University Hospitals NHS Trust

 

P337      Measuring postural blood pressure to reduce the risk of falls in haemodialysis patients: development of a quality improvement project

Jennifer Allen

Nottingham University Hospitals NHS Trust

 

P338      Use of ultrasound (SonoSite NanoMaxxTM) by registered haemodialysis nurses to assess and cannulate arteriovenous fistulae and grafts – a case study 

Anthoula Apostolidi       

DCHFT

 

P339      Shared care - one unit's journey

Jyoti Baharani   

Heart Of England Foundation Trust

 

P340      Improving Fluid Assessments in Acute Haemodialysis

Ellen Caffrey     

Belfast Health and Social Care Trust

 

P343      Comparison of the FX120 haemodialyser with the FX1000 haemodiafilter in post-dilution haemodiafiltration

Elizabeth Lindley             

Leeds Teaching Hospitals NHS Trust

 

P344      MASKED FRAILTY IS HIGHLY PREVALENT IN HAEMODIALYSIS PATIENTS AND PERTINENT TO APPROPRIATE CLINICAL DECISION MAKING      

Stephanie Poo  

Imperial College London

 

P345      Dual compartment monitoring to estimate vascular refill during haemodialysis

Sivaramakrishnan Ramanarayanan          

Lister Hospital, East and North Hertfordshire trust

 

P346      Holistic care for dialysis patients - when QOL trumps adequacy

Stephanie Walker           

Heart of England Foundation Trust

 

Group 31: Clinical -  Haemodialysis and Clinical -  Vascular Access

Moderated by Stephanie Stringer and Nick Farndon

 

P347      NO MONEY…NO TREATMENT…NO LIFE: PATIENT EXPERIENCE OF DIALYSIS IN NIGERIA

Chidiebere Ekuma          

School Of Health, University Of Salford, Manchester

 

P348      The SIMPLIFIED Registry Trial: Towards Delivery of Streamlined Dialysis Trials in the United Kingdom.

Thomas Hiemstra             

University Of Cambridge

 

P349      How to reduce infections related to vascular access (VA) for haemodialysis: A single-centre retrospective study

Toby Humphrey

Addenbrooke's Hospital

 

P350      Chlorhexidine induced dermatitis for haemodialysis patients - Improving patient outcome by using Octenilin as alternative skin preparation  

Karen Huxtable

Plymouth Hospital NHS Trust

 

P351      Syner-KINASE for restoration of patency in tunnelled central venous haemodialysis catheter obstruction – results from a prospective multicentre study (PASSPORT study)

Mick Kumwenda             

Glan Clwyd Hospital Rhyl

 

P352      Cambridge experience using plastic needles to cannulate an Arteriovenous Fistula            

Regin Lagaac

Cambridge University Hospitals NHS Ft

 

P353      Tattoo of Vascular Cannulation Site as A SELF-CANNULATION AID

Regin Lagaac     

Cambridge University Hospitals NHS Ft

 

P354      Far Infrared Treatment for Arteriovenous Fistula (AVF)

Regin Lagaac

Cambridge University Hospitals NHS Ft

 

P355      Haemodialysis Controversy: Creating Ankle Arteriovenous Fistula as access for Haemodialysis      

Regin Lagaac     

Cambridge University Hospitals NHS Ft

 

P356      Developing a Renal Early Warning Score System for Haemodialysis Patients          

Joseph  Newton

Salford Royal NHS Foundation Trust

 

P357      The care of patients on a one bedded “renal unit” at a cardiothoracic transplant centre

Charlotte O' Toole

University Hospitals of South Manchester

 

P358      Pre-emptive Haemodialysis Post-Melphalan for Patients with Renal Impairment receiving Autologous Stem Cell Transplant for Multiple Myeloma.

Apexa Patel       

University Hospitals of Leicester

 

P359      OUTCOMES OF A PATIENT COHORT ON ASSISTED AUTOMATED PERITONEAL DIALYSIS – FOUR YEARS EXPERIENCE FROM A SINGLE UK CENTRE

Fatima Abdelaal               

Birmingham Heartlands Hospital

 

Group 32: Clinical -  Home Therapies

Moderated by Nitin Kolhe and Nicola Thomas

 

P360      Evaluating the impact of Quality Improvement on a Peritoneal Dialysis Programme

Jyoti Baharani

Heart of England Foundation Trust

 

P361      A Comparison of Clinical Outcomes in Home Haemodialysis between NxStage and Conventional High Flux Haemodialysis or Haemodiafiltration

Hannah Beckwith

Imperial College

 

P362      Home dialysis: first or second class travel?           

Tracey Bellwood              

East & North Herts NHS Trust

 

P363      Changes in dialysis prescription affect the time course of solute transport in peritoneal dialysis   

Irene Brenna     

Royal Stoke University Hospital

 

P364      Home Haemodialysis Annual review - a valuable tool

Colette Doyle   

University Hospital Birmingham NHS Foundation Trust

 

P365      Home dialysis and patient choice roadshows – a collaborative and practical approach to raising awareness with patients, dialysis units and industry working together

Fiona Loud         

Kidney Care UK

 

P366      Using a two-way Remote Patient Management system to Tailor APD therapy.

Kate Mccarthy  

Baxter Healthcare

 

P367      Increasing the uptake of Home Haemodialysis by using focused education and awareness for staff in the wider renal community.

Nicola Pacy

Wessex Kidney Centre

 

P368      Improving the pathway for Home Haemodialysis: National Nurses Board (NNB)

Nicola Pacy        

Wessex Kidney Centre

 

P369      Impact of Nocturnal haemodialysis on Erythropoietin responsiveness

Tim Scale            

Morriston Hospital

 

Group 33: Clinical – Biomarkers and Clinical - Genetic Disorders

Moderated by Paul Warwicker and TBC

P371      Long term management of a family with Calcium – sensing receptor mutation.

Shahid  Abdullah             

Freeman Hospital

 

P373      Associations of Cardio-Renal Biomarkers in Chronic Kidney Disease patients with Non-Alcoholic Fatty Liver Disease

Rajkumar Chinnadurai   

Salford Royal NHS Foundation Trust

 

P374      Treating Autosomal Dominant Polycystic Kidney Disease with Tolvaptan: A Year in Practice

Jiehan Chong

Sheffield Kidney Institute

 

P375      The DRINK Randomised Feasibility Trial: Determining feasibility of Randomisation to high versus ad libitum water Intake in Polycystic Kidney Disease             

Ragada El-damanawi     

University Of Cambridge

 

P376      A novel biomarker of laminin turnover is associated with progression to end stage renal disease and mortality in chronic kidney disease             

Anthony Fenton              

University Hospitals Birmingham NHS Foundation Trust

 

P377      Variable phenotypic presentations of renal involvement in Fabry Disease

Sarah     McCloskey         

Freeman Hospital

 

P378      Development of a regional expert clinic for the evaluation and treatment of patients with renal complications of Tuberous Sclerosis Complex (TSC)       

Julie Nichols      

Sheffield Teaching Hospitals NHS Trust

 

P379      ADPKD RaDaR-will it change what we know about ADPKD and how we manage patients?

Richard Sandford            

University Of Cambridge

 

P380      Tolvaptan for the treatment of autosomal dominant polycystic kidney disease within a multi-disciplinary team clinic setting - a North East experience  

John Sayer         

Newcastle University

 

P381      Calcium stones in cystinuria: co-incidence, combined pathology or complications of treatment?

John Sayer         

Newcastle University

 

P382      Use of Tolvaptan in a high risk ADPKD clinic: first 22 patient months         

Neil Turner        

University of Edinburgh

 

Group 34: Clinical - Conservative/End of Life Care

Moderated by Edwina Brown and Ken Farrington

 

P383      Advanced Care Planning-time well spent              

Wendy Baird     

Ulster Hospital Dundonald

 

P384      Why do patients planned for renal replacement therapy change their mind to maximum conservative management? 

Aditi Chitale       

Royal Free Hospital

 

P385      Care of patients withdrawing from outpatient haemodialysis.

Pamela Davison

York Teaching Hospital

 

P386      End of Life Care Registers for Dialysis Patients in UK Renal Units

Natasha Freeman           

Heart of England NHS Foundation Trust

 

P387      Developing a renal supportive care programme for patients undergoing maintenance haemodialysis and peritoneal dialysis. Utilising the results of a qualitative study exploring the knowledge, views and experience of ‘front line’ dialysis health care professionals.

Deborah Grove

Oxford University Hospitals NHS Foundation Trust

 

P388      Dying with kidney disease- when, where and how?          

Elise Hardwick  

University of Manchester

 

P389      A collaborative experience: Joint renal and palliative care nurse led clinics.            

Nicola Henawi  

Royal Free London NHS Foundation

 

P391      5 Year Experience of Organising an Annual Bereavement Service for Renal Carers - Single Centre Experience from the UK      

Sonia Miller       

Birmingham Heartlands Hospital

 

P392      A retrospective multivariate outcome analysis comparing renal replacement therapy to active supportive care in patients over 80 years old with end stage renal failure.             

Emma Montgomery      

Newcastle Upon Tyne Hospitals

 

P393      The views and experiences of older people with conservatively managed renal failure: a qualitative study of communication, information and decision-making

Lucy Selman      

University of Bristol

 

P394      Supporting patient preferences in end of life care.            

Kim        Sinnamon           

Colchester Hospital

 

P395      A retrospective study of planning in ESRF and end-of-life care in conservative care versus haemodialysis deaths in a Low Clearance Clinic environment    

David Robert Wandless

NHS Grampian

 

Group 35: Laboratory Science -  Fibrosis and extracellular matrix and Laboratory Science -  Glomerular cell pathobiology

Moderated by Timothy Bowen and Bruce Hendry

 

P396      The Regulation of Expression and Anti-Fibrotic Actions of CCN3/NOV in the Presence of TGFβ

Abigail Dear       

South West Thames Institute for Renal Research

 

P397      Endothelial-to-mesenchymal transition contributes to renal fibrosis and is associated with changes in miRNA expression

Emily Glover     

Newcastle University

 

P398      The insulin/IGF axis is critical for podocyte function but only when these receptors are suppressed by more than 95%

Jenny Hurcombe             

University Of Bristol

 

P400      Kidney function below par: The Key Role of the PAR-1 Receptor in the Podocyte in circulating factor Nephrotic Syndrome.         

Carl May             

Bristol Renal

 

P401      The role of the methyltransferase SETDB1 in Chronic Kidney Disease

Victoria Shuttleworth    

Newcastle University

 

P402      Aristolochic Acid induced AKI to CKD: Regulation of fibronectin splicing as a putative approach to prevent progression.      

Pritpal   Virdee 

South West Thames Institute for Renal Research

 

P403      Hyaluronan generated during peritoneal dialysis does not drive fibrosis, but regulates inflammatory cell recruitment during peritoneal infection.

Aled Williams    

Cardiff University

 

P405      Proteomic analysis of TGF-β1-induced fibrogenesis and mechanisms of action of antifibrotics in renal fibroblasts          

Qihe Xu

King's College London

 

roup 36: Clinical -  Innovations in Practice and Laboratory Science -  Diabetes and the Kidney

Moderated by Mark Dockrell and Andrew Frankel

 

P406      FIBROSIS-RELATED MicroRNAs ARE DYSREGULATED BY HYPERGLYCAEMIA IN HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS

Fahad Alsehli    

Manchester Metropolitan University

 

P407      Insulin signaling regulates bioenergetics in podocytes    

Virginie Betin    

University Of Bristol

 

P408      A high-content imaging assay for quantifying mitochondrial function and density in the podocyte              

Mark Graham   

University Of Bristol

 

P409      Medical Alert Cards for People with Chronic Kidney Disease: Improving Patient Safety and Experience

Caroline Judge 

East Kent Hospitals NHS Foundation Trust

 

P410      A systems biology approach to explore cell-specific changes in diabetic kidney disease

Abigail Lay          

University Of Bristol

 

P411      How do family and informal carers of patients undergoing HD influence adherence to treatment? – A systematic review of the literature.         

Mari McPeake  

NHSct

 

P412      Experiences of effectively enhancing clinical informatics and outcomes following the installation of a new electronic patient record.            

Johann Nicholas              

Shrewsbury and Telford Hospitals

 

P413      Deleting Cav3.1 using gene editing reduces mesangial cell proliferation and phosphorylation of ERK in vitro               

Sudha Priya Soundara Pandi       

Kings College London

 

P414      Glomerular IGFBP1 is down regulated in diabetic nephropathy and is important for podocyte function    

Holly Stowell-Connolly 

University of Bristol

 

P415      Responding to the information needs of patients with IgA nephropathy; a digital solution using social media               

Cristina Vasilica

University of Salford

 

P416      DDIP:  Diabetes and Dialysis Improvement Project - A Quality Improvement Project to Improve Foot Health Outcomes in Diabetic Dialysis Patients   

Nicole Williams 

St James' University Hospital, Leeds

 

P417      PTP1B inhibitors can reverse the high glucose induced pathological changes in human podocytes, independent of insulin receptor signalling.      

Heather M Wilson

University of Aberdeen

 

Group 37: Late Breaking Abstracts

Moderated by Al Ferraro and Lisa Willcocks

 

P418      A quality improvement project to improve the recognition and basic management of Acute Kidney Injury (AKI)               

Kaenat  Mulla    

BHRUT

 

P418      Development of an Imaging Toolbox to Study Organ Function and Cellular Biodistribution for Regenerative Therapies

Jack Sharkey     

University Of Liverpool

 

P419      Renal Adverse Events Associated with Immunotherapy: Experience at a Large Cancer Centre

Peter Hill             

Imperial College Healthcare NHS Trust

 

P420      Elevation of serum creatinine in a renal transplant patient following the use of creatine supplements      

Saveria Di Gerlando       

Queen Elizabeth Hospital Birmingham

 

P421      Demographics and Outcomes of Patients Receiving Intermittent Haemodialysis for AKI Outside of Intensive Care      

Andrew Lewington          

St. James's University Hospital Trust

 

P422      Repatriation of patients to referral centres and outcomes after kidney transplantation.  

Khalid Khalil

University of Birmingham

 

P423      Reducing burden on patients, improving treatment data: introduction of Nx2Me in a single centre home haemodialysis population            

Carol Rhodes    

Derby Hospital

 

P425      How do we increase Living Donor Kidney Transplantation (LDKT)?: Report of a region wide event to identify barriers and solutions.  

Kerry Tomlinson              

University Hospitals North Midlands

 

P426      Generic ciclosporin: supervised switch programme for renal transplant recipients from Neoral-ciclosporin to Vanquoral-ciclosporin: Interim analysis  

Andrea Devaney             

Oxford Transplant Centre, OUHFT

 

P427 An Unusual Case of Hypoparathyroidism with Basal Ganglia Calcification

Muhammad Tassaduq Khan       

Renal Transplant Unit, National Institute of Solid Organ and Tissue Transplant, Dow University of Health Sciences